Immunogenicity and safety of homologous and heterologous ChAdOx1-S and mRNA-1273 vaccinations in healthy adults in Taiwan

BACKGROUND: : In Taiwan, the vaccination program started in March 2021, with ChAdOx1-S being the first available WHO-approved COVID-19 vaccine, followed by Moderna vaccine. This study aimed to investigate the immunogenicity and safety of homologous and heterologous prime-boost regimens with ChAdOx1-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Chun-Min, Lee, Nan-Yao, Lin, Chih-Hsueh, Hsu, Yuan-Shan, Chang, Yu-Chang, Chung, Ming-Yi, Lee, Ya-Fan, Tseng, Wen-Pin, Wu, Jhong-Lin, Chen, Shey-Ying, Lu, Min-Chi, Ko, Wen-Chien, Lee, Ping-Ing, Hsueh, Po-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986279/
https://www.ncbi.nlm.nih.gov/pubmed/35413588
http://dx.doi.org/10.1016/j.jcv.2022.105156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986279/
https://www.ncbi.nlm.nih.gov/pubmed/35413588
http://dx.doi.org/10.1016/j.jcv.2022.105156

Ejemplares similares